Catalyst Biosciences Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters2023-08-12

* Catalyst Biosciences Inc is expected to show no change in quarterly revenue when it reports results on August 14 (estimated).

*

* ​Refinitiv's mean analyst estimate for Catalyst Biosciences Inc is for a loss of 7 cents per share.

* The one available analyst rating on the shares is "hold".

* The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated August 12 at 02:04 GMT. All figures in US dollars unless otherwise stated.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment